article thumbnail

Bormioli Pharma Invents: pioneering a connected future in pharmaceutical packaging

Digital Health Global

In the ever-evolving landscape of pharmaceuticals, innovation has become a guiding force for companies toward a future where healthcare is not only effective but seamlessly integrated into our daily lives. The company envisions a future where connected devices enhance patient care and pharmaceutical packaging simultaneously.

article thumbnail

Pharmaceutical Multinationals Continue To Spurn The Opportunity To Connect Via Social Media At A Local Level

Digital Health Global

The Report shows that the world’s leading pharmaceutical companies continue to spurn the opportunity to connect via social media at a local level. Roche Pharmaceuticals 3. Bayer (Pharmaceuticals Division) 4. Pfizer, Janssen, Novartis, Novo Nordisk, AbbVie and Takeda Pharmaceutical have at least 11 local apps available.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aptar Digital Health and Iona Mind Announce Partnership to Deliver Scalable Mental Health Support to Chronic Disease Patients

Digital Health Global

Benefiting from the combined capabilities and digital platforms of both organizations, the partnership will provide integrated solutions to pharmaceutical partners aiming to enhance patient experiences. The Iona Mind platform contains low-intensity CBT programs for managing common mental health conditions and general wellbeing.

article thumbnail

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Digital Health Global

(Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.

article thumbnail

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Digital Health Global

Today’s announcement comes following the October 2023 acquisition of Healthware Group , an agency and innovation consultancy headquartered in Salerno, Italy. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world.

article thumbnail

Transforming Pharma through Digital Innovation

Digital Health Global

In an era where technological advancements drive transformative changes across industries, the pharma industry is witnessing a significant shift towards digital health solutions. At the forefront of this evolution is Debiopharm Innovation Fund , a corporate venture fund within the Debiopharm Group.